MEGA GENOMICS (06667) announced its 2024 financial results, achieving operating revenue of approximately 164 million yuan, an increase of 8.5% compared to the previous year. The company realized a net profit of 45 million yuan, representing a significant year-on-year growth of 50.0%. Earnings per share stood at 0.22 yuan. According to the announcement, this performance was primarily driven by the company's persistent focus on product design innovation, continuous enrichment of its product portfolio, and optimization of its product structure. Simultaneously, the company adopted an aggressive market expansion strategy, actively exploring more sales scenarios and channels, continuously uncovering latent market demand and sales opportunities. It has also established a diversified sales system and further enhanced the customer service experience, collectively driving steady growth in both revenue and net profit.